Jane Street’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-90,141
Closed -$10.5M 5428
2025
Q1
$10.5M Buy
90,141
+11,692
+15% +$1.36M ﹤0.01% 794
2024
Q4
$6.64M Sell
78,449
-51,648
-40% -$4.37M ﹤0.01% 972
2024
Q3
$11.7M Sell
130,097
-38,337
-23% -$3.45M ﹤0.01% 681
2024
Q2
$13.6M Sell
168,434
-30,645
-15% -$2.47M ﹤0.01% 849
2024
Q1
$15.9M Buy
199,079
+106,248
+114% +$8.48M ﹤0.01% 589
2023
Q4
$7.39M Sell
92,831
-32,750
-26% -$2.61M ﹤0.01% 1170
2023
Q3
$8.78M Sell
125,581
-150,321
-54% -$10.5M ﹤0.01% 927
2023
Q2
$19.8M Buy
275,902
+254,158
+1,169% +$18.3M 0.01% 575
2023
Q1
$1.34M Sell
21,744
-154,155
-88% -$9.51M ﹤0.01% 2473
2022
Q4
$13.6M Sell
175,899
-6,971
-4% -$538K 0.01% 529
2022
Q3
$8.16M Buy
182,870
+140,975
+336% +$6.29M ﹤0.01% 803
2022
Q2
$1.6M Buy
41,895
+1,336
+3% +$51.2K ﹤0.01% 2240
2022
Q1
$1.68M Sell
40,559
-358,235
-90% -$14.8M ﹤0.01% 2328
2021
Q4
$15.1M Buy
398,794
+105,462
+36% +$3.98M 0.01% 461
2021
Q3
$9.67M Buy
293,332
+190,621
+186% +$6.28M ﹤0.01% 609
2021
Q2
$6.93M Buy
102,711
+10,539
+11% +$711K ﹤0.01% 731
2021
Q1
$5.22M Buy
92,172
+19,918
+28% +$1.13M ﹤0.01% 793
2020
Q4
$5.89M Sell
72,254
-107,001
-60% -$8.72M ﹤0.01% 627
2020
Q3
$12.8M Buy
179,255
+119,216
+199% +$8.49M 0.01% 291
2020
Q2
$4.94M Sell
60,039
-50,121
-45% -$4.12M ﹤0.01% 708
2020
Q1
$6.48M Sell
110,160
-57,496
-34% -$3.38M 0.01% 444
2019
Q4
$17.3M Buy
167,656
+155,206
+1,247% +$16M 0.02% 131
2019
Q3
$252K Buy
12,450
+392
+3% +$7.93K ﹤0.01% 2843
2019
Q2
$310K Sell
12,058
-7,092
-37% -$182K ﹤0.01% 2706
2019
Q1
$273K Buy
+19,150
New +$273K ﹤0.01% 2772